欧洲宏基因组学市场至 2027 年 - 按产品(仪器、软件和消耗品)、应用(临床诊断、药物发现宏基因组学等)和国家/地区进行区域分析和预测

Historic Data: 2016-2017   |   Base Year: 2018   |   Forecast Period: 2019-2027


No. of Pages: 138    |    Report Code: TIPRE00003321    |    Category: Life Sciences

Europe Metagenomics Market

欧洲宏基因组学市场预计将从 2018 年的 4860 万美元增至 2027 年的 8970 万美元。预计 2018-2027 年该市场的复合年增长率为 7.4% .

宏基因组学技术进步、宏基因组学相对于传统方法的日益偏好以及广泛的宏基因组学应用等因素推动了市场的增长,在欧洲地区。然而,高价的宏基因组技术可能会对未来几年市场的增长产生负面影响。

宏基因组学是生物技术的新兴领域,广泛应用世界各地的实验室正在进行研究。此外,下一代测序和基因组学中的其他技术正在协助宏基因组学研究的进行。此外,近年来,下一代测序的价格大幅下降。例如,2000 年首次进行的人类全基因组测序耗资超过 37 亿美元,历时 13 年才完成。然而,近年来其成本已降至 1,000 美元,且流程所需的天数也更少。 2000年,测序成本为37亿美元,2006年降至1000万美元,2012年降至5000美元。总部位于英国的牛津纳米孔技术公司是欧洲为数不多的生物技术独角兽公司之一,推出了突破性技术在DNA测序中。该公司开发了手持式 MinION 测序仪来对人类基因组进行测序。该设备能够读取比平常大数百倍的DNA序列,帮助科学家更好地重建整个基因组序列。 MinION 的成本不到 1,000 美元,即使在实验室外也能提供高速测序,使用“纳米抛光”技术时准确度高达 99.96%。

由于宏基因组学的成本得到了风险投资家的补贴以及市场领导者的创新技术,使得获得宏基因组学研究可能会推动预测期内市场的增长。

德国被认为是欧洲和世界上最大的生物技术中心由于存在大型生物技术参与者、高科技研究实验室以及用于研究和开发的大量资金。德国是欧洲生物技术公司最多的国家。该国在正在进行的研究数量方面也名列国际前列。该国现有的尖端和高质量研究为宏基因组学创造了利润丰厚的机会和成熟的市场。

欧洲其他地区宏基因组学市场到 2027 年的收入和预测(十亿美元)


欧洲宏基因组学 - 市场细分


按产品


  • 仪器仪表软件
  • 耗材

欧洲宏基因组学 - 市场细分



按应用


  • 临床诊断
  • 药物发现

按国家


  • 法国
  • 德国
  • 英国

提及的公司


  • 默克公司
  • Thermo Fisher Scientific Inc.
  • 安捷伦科技
  • Qiagen
  • Bio-Rad Laboratories, Inc.
  • < span>Perkinelmer Inc.
  • Illumina Inc.
  • F Hoffman-La Roche Ltd.
  • 牛津纳米孔技术有限公司
  • 加州太平洋生物科学公司


Europe Metagenomics Strategic Insights

Strategic insights for Europe Metagenomics involve closely monitoring industry trends, consumer behaviours, and competitor actions to identify opportunities for growth. By leveraging data analytics, businesses can anticipate market shifts and make informed decisions that align with evolving customer needs. Understanding these dynamics helps companies adjust their strategies proactively, enhance customer engagement, and strengthen their competitive edge. Building strong relationships with stakeholders and staying agile in response to changes ensures long-term success in any market.

strategic-framework/europe-metagenomics-market-strategic-framework.webp
Get more information on this report

Europe Metagenomics Report Scope

Report Attribute Details
Market size in 2018 US$ 48.6 Million
Market Size by 2027 US$ 89.7 Million
Global CAGR (2018 - 2027) 7.4%
Historical Data 2016-2017
Forecast period 2019-2027
Segments Covered By 产品
  • 仪器
  • 软件和耗材
By 应用
  • 临床诊断
  • 药物发现宏基因组学
Regions and Countries Covered 欧洲
  • 英国
  • 德国
  • 法国
  • 俄罗斯
  • 意大利
  • 欧洲其他地区
Market leaders and key company profiles
  • Merck KGaA
  • Thermo Fisher Scientific Inc.
  • Agilent Technologies
  • Qiagen
  • Bio-Rad Laboratories, Inc.
  • Perkinelmer Inc.
  • Illumina Inc.
  • F Hoffman-La Roche Ltd.
  • Oxford Nanopore Technologies Ltd.
  • Pacific Bioscience of California, Inc.
  • Get more information on this report

    Europe Metagenomics Regional Insights

    The regional scope of Europe Metagenomics refers to the geographical area in which a business operates and competes. Understanding regional nuances, such as local consumer preferences, economic conditions, and regulatory environments, is crucial for tailoring strategies to specific markets. Businesses can expand their reach by identifying underserved regions or adapting their offerings to meet regional demands. A clear regional focus allows for more effective resource allocation, targeted marketing, and better positioning against local competitors, ultimately driving growth in those specific areas.

    geography/europe-metagenomics-market-geography.webp
    Get more information on this report

    The List of Companies - Europe Metagenomics Market

    The List of Companies - Europe Metagenomics Market

    1. Merck KGaA
    2. Thermo Fisher Scientific Inc.
    3. Agilent Technologies
    4. Qiagen
    5. Bio-Rad Laboratories, Inc.
    6. Perkinelmer Inc.
    7. Illumina Inc.
    8. F Hoffman-La Roche Ltd.
    9. Oxford Nanopore Technologies Ltd.
    10. Pacific Bioscience of California, Inc.
    Frequently Asked Questions
    How big is the Europe Metagenomics Market?

    The Europe Metagenomics Market is valued at US$ 48.6 Million in 2018, it is projected to reach US$ 89.7 Million by 2027.

    What is the CAGR for Europe Metagenomics Market by (2018 - 2027)?

    As per our report Europe Metagenomics Market, the market size is valued at US$ 48.6 Million in 2018, projecting it to reach US$ 89.7 Million by 2027. This translates to a CAGR of approximately 7.4% during the forecast period.

    What segments are covered in this report?

    The Europe Metagenomics Market report typically cover these key segments-

  • 产品 (仪器, 软件和耗材)
  • 应用 (临床诊断, 药物发现宏基因组学)
  • What is the historic period, base year, and forecast period taken for Europe Metagenomics Market?

    The historic period, base year, and forecast period can vary slightly depending on the specific market research report. However, for the Europe Metagenomics Market report:

  • Historic Period : 2016-2017
  • Base Year : 2018
  • Forecast Period : 2019-2027
  • Who are the major players in Europe Metagenomics Market?

    The Europe Metagenomics Market is populated by several key players, each contributing to its growth and innovation. Some of the major players include:

  • Merck KGaA
  • Thermo Fisher Scientific Inc.
  • Agilent Technologies
  • Qiagen
  • Bio-Rad Laboratories, Inc.
  • Perkinelmer Inc.
  • Illumina Inc.
  • F Hoffman-La Roche Ltd.
  • Oxford Nanopore Technologies Ltd.
  • Pacific Bioscience of California, Inc.
  • Who should buy this report?

    The Europe Metagenomics Market report is valuable for diverse stakeholders, including:

    • Investors: Provides insights for investment decisions pertaining to market growth, companies, or industry insights. Helps assess market attractiveness and potential returns.
    • Industry Players: Offers competitive intelligence, market sizing, and trend analysis to inform strategic planning, product development, and sales strategies.
    • Suppliers and Manufacturers: Helps understand market demand for components, materials, and services related to concerned industry.
    • Researchers and Consultants: Provides data and analysis for academic research, consulting projects, and market studies.
    • Financial Institutions: Helps assess risks and opportunities associated with financing or investing in the concerned market.

    Essentially, anyone involved in or considering involvement in the Europe Metagenomics Market value chain can benefit from the information contained in a comprehensive market report.